Impaired coronary flow reserve as a marker of microvascular dysfunction to predict long-term cardiovascular outcomes, acute coronary syndrome and the development of heart failure

Circulation Journal

Volumn 76, Issue 8, 2012, Pages 1958-1964

  Nakanish, Koki ^a   Fukuda, Shota ^b   Shimada, Kenei ^a   Miyazaki, Chinami ^c   Otsuka, Kenichiro ^a   Maeda, Kumiko ^b   Miyahana, Reiko ^b   Kawarabayashi, Takahiko ^c   Watanabe, Hiroyuki ^d   Yoshikawa, Junichi ^e   Yoshiyama, Minoru ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka Ekisaikai Hospital   (Japan)

^c Higashisumiyoshi Morimoto Hospital   (Japan)

^d TOKYO BAY URAYASU ICHIKAWA MEDICAL CENTER   (Japan)

^e Nishinomiya Watanabe Cardiovascular Center   (Japan)

Author keywords

Acute coronary syndrome; Coronary flow reserve; Heart failure

Indexed keywords

C REACTIVE PROTEIN;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD FLOW VELOCITY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; DIAGNOSTIC ACCURACY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PREDICTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TRANSTHORACIC DOPPLER ECHOCARDIOGRAPHY; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 84864378858     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0245     Document Type: Article

References (41)

1. Hirata K, Amudha K, Elina R, Hozumi T, Yoshikawa J, Homma S, et al. Measurement of coronary vasomotor function: Getting to the heart of the matter in cardiovascular research. Clin Sci (Lond) 2004; 107: 449-460.
2. Daimon M, Watanabe H, Yamagishi H, Muro T, Akioka K, Hirata K, et al. Physiologic assessment of coronary artery stenosis by coronary flow reserve measurements with transthoracic Doppler echocardiography: Comparison with exercise thallium-201 single piston emission computed tomography. J Am Coll Cardiol 2001; 37: 1310-1315.
3. Takeuchi M, Miyazaki C, Yoshitani H, Otani S, Sakamoto K, Yoshikawa J. Assessment of coronary flow velocity with transthoracic Doppler echocardiography during dobutamine stress echocardiography. J Am Coll Cardiol 2001; 38: 117-123.
4. Cortigiani L, Rigo F, Gherardi S, Sicari R, Galderisi M, Bovenzi F, et al. Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 2007; 50: 1354-1361.
5. Sicari R, Rigo F, Cortigiani L, Gherardi S, Galderisi M, Picano E. Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries. Am J Cardiol 2009; 103: 626-631.
6. Rigo F, Sicari R, Gherardi S, Djordjevic-Dikic A, Cortigiani L, Picano E. Prognostic value of coronary flow reserve in medically treated patients with left anterior descending coronary disease with stenosis 51% to 75% in diameter. Am J Cardiol 2007; 100: 1527-1531.
7. Rosen BD, Lima JA, Nasir K, Edvardsen T, Folsom AR, Lai S, et al. Lower myocardial perfusion reserve is associated with decreased regional left ventricular function in asymptomatic participants of the multi-ethnic study of atherosclerosis. Circulation 2006; 114: 289-297.
8. Galderisi M, Cicala S, Caso P, De Simone L, D'Errico A, Petrocelli A, et al. Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 2002; 90: 860-864.
9. Pop-Busui R, Kirkwood I, Schmid H, Marinescu V, Schroeder J, Larkin D, et al. Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction. J Am Coll Cardiol 2004; 44: 2368-2374.
10. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
11. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 2002; 106: 1893-1900.
12. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971; 285: 1441-1446.
13. How to diagnose diastolic heart failure: European Study Group on Diastolic Heart Failure. Eur Heart J 1998; 19: 990-1003.
14. Hozumi T, Yoshida K, Akasaka T, Asami Y, Ogata Y, Takagi T, et al. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: Comparison with invasive technique. J Am Coll Cardiol 1998; 32: 1251-1259.
15. Caiati C, Montaldo C, Zedda N, Bina A, Iliceto S. New noninvasive method for coronary flow reserve assessment: Contrast-enhanced transthoracic second harmonic echo Doppler. Circulation 1999; 99: 771-778.
16. Shimada K, Watanabe H, Hosoda K, Takeuchi K, Yoshikawa J. Effect of red wine on coronary flow-velocity reserve. Lancet 1999; 354: 1002.
17. Otsuka R, Watanabe H, Hirata K, Tokai K, Muro T, Yoshiyama M, et al. Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA 2001; 286: 436-441.
18. Fukuda S, Shimada K, Kawasaki T, Kono Y, Jissho S, Taguchi H, et al. "Passive exercise" using whole body periodic acceleration: Effects on coronary microcirculation. Am Heart J 2010; 159: 620-626.
19. Lee DH, Youn HJ, Choi YS, Park CS, Park JH, Jeon HK, et al. Coronary flow reserve is a comprehensive indicator of cardiovascular risk factors in subjects with chest pain and normal coronary angiogram. Circ J 2010; 74: 1405-1414.
20. Kinlay S, Ganz P. Relation between endothelial dysfunction and the acute coronary syndrome: Implications for therapy. Am J Cardiol 2000; 86: 10J-13J.
21. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109: III27-III32.
22. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-671.
23. Davies MJ. The composition of coronary-artery plaques. N Engl J Med 1997; 336: 1312-1314.
24. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-487.
25. Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996; 94: 258-265.
26. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, et al. T-786 → C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864-2870.
27. Skalidis EI, Parthenakis FI, Patrianakos AP, Hamilos MI, Vardas PE. Regional coronary flow and contractile reserve in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2004; 44: 2027-2032.
28. Olivotto I, Cecchi F, Gistri R, Lorenzoni R, Chiriatti G, Girolami F, et al. Relevance of coronary microvascular flow impairment to longterm remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006; 47: 1043-1048.
29. Palombo C, Kozakova M, Magagna A, Bigalli G, Morizzo C, Ghiadoni L, et al. Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients. J Hypertens 2000; 18: 453-459.
30. Sugioka K, Hozumi T, Takemoto Y, Ehara S, Ogawa K, Iwata S, et al. Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy. Am Heart J 2007; 153: 1080 e1-e6.
31. Wisniacki N, Taylor W, Lye M, Wilding JP. Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure. Heart 2005; 91: 32-37.
32. Schafer S, Kelm M, Mingers S, Strauer BE. Left ventricular remodeling impairs coronary flow reserve in hypertensive patients. J Hypertens 2002; 20: 1431-1437.
33. Fiordaliso F, Leri A, Cesselli D, Limana F, Safai B, Nadal-Ginard B, et al. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 2001; 50: 2363-2375.
34. Paulus WJ, Shah AM. NO and cardiac diastolic function. Cardiovasc Res 1999; 43: 595-606.
35. Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM, et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 2010; 55: 2825-2832.
36. British Cardiac Society; British Hypertension Society; Diabetes UK; HEART UK; Primary Care Cardiovascular Society; Stroke Association. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91: v1-v52.
37. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113: 2363-2372.
38. Sangiorgi G, Biondi-Zoccai G. Pharmacological engineering of endothelial function and vessel response to drug-eluting stents: Do-ityourself with calcium-channel and angiotensin-receptor blockers. Circ J 2010; 74: 1536-1537.
39. Reis SE, Holubkov R, Lee JS, Sharaf B, Reichek N, Rogers WJ, et al. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease: Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol 1999; 33: 1469-1475.
40. Serruys PW, de Bruyne B, Carlier S, Sousa JE, Piek J, Muramatsu T, et al. Randomized comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement: Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) II Study Group. Circulation 2000; 102: 2930-2937.
41. Di Mario C, Moses JW, Anderson TJ, Bonan R, Muramatsu T, Jain AC, et al. Randomized comparison of elective stent implantation and coronary balloon angioplasty guided by online quantitative angiography and intracoronary Doppler: DESTINI Study Group (Doppler Endpoint STenting INternational Investigation). Circulation 2000; 102: 2938-2944.